DNA encoding a plasminogen activating protein
AssigneePfizer Inc.
InventorsEverett L. Rosey, Robert J. Yancey, Jr., James A. Leigh
Life of this patent
Estimating the term…
Loading patent…
AssigneePfizer Inc.
InventorsEverett L. Rosey, Robert J. Yancey, Jr., James A. Leigh
Estimating the term…
The present invention provides polynucleotide molecules comprising nucleotide sequences encoding plasminogen activating (PauA) proteins from Streptococcus uberis, and substantially homologous polypeptides, peptide fragments, and fusion proteins thereof. The present invention further provides compositions and methods for recombinantly expressing the PauA proteins, substantially homologous polypeptides, peptide fragments and fusion proteins encoded by the polynucleotide molecules of the present invention. The present invention further provides a vaccine for protecting a member of a mammalian species against mastitis, comprising a PauA protein, substantially homologous polypeptide, peptide fragment, fusion protein, or polynucleotide molecule of the present invention.
An isolated polynucleotide molecule, comprising a nucleotide sequence encoding a protein comprising the amino acid sequence from amino acid position 26 to amino acid position 286 of SEQ ID NO:2 or SEQ ID NO:4.
An isolated polynucleotide molecule that hybridizes to a DNA molecule comprising a nucleotide sequence complementary to the nucleotide sequence from nucleotide position 195 to nucleotide position 447 of SEQ ID NO:1, or from nucleotide position 196 to nucleotide position 448 of SEQ ID NO:3, under conditions of 0.5M NaHPO4, 7% sodium dodecyl sulfate (SDS), 1 mM EDTA at 65° C., and washing in 0.2×SSC/0.1% SDS at 42° C., and which polynucleotide molecule encodes a polypeptide that, when administered to a member of a mammalian species, is capable of inducing the production of antibodies that bind specifically to a protein comprising the amino acid sequence from amino acid position 26 to amino acid position 286 of SEQ ID NO:2 or SEQ ID NO:4.
An isolated polynucleotide molecule, comprising a nucleotide sequence encoding a peptide fragment of a protein consisting of the amino acid sequence of SEQ ID NO:2 or SEQ ID NO:4, which peptide fragment, when administered to a member of a mammalian species, is capable of inducing the production of antibodies that bind specifically to a protein comprising the amino acid sequence from amino acid position 26 to amino acid position 286 of SEQ ID NO:2 or SEQ ID NO:4.
An isolated polynucleotide molecule comprising a nucleotide sequence encoding a fusion protein, said fusion protein comprising a fusion partner fused to a protein comprising the amino acid sequence from amino acid position 26 to amino acid position 286 of SEQ ID NO:2 or SEQ ID NO:4.
An isolated polynucleotide molecule comprising a nucleotide sequence encoding a fusion protein, said fusion protein comprising a fusion partner fused to a peptide fragment of a protein consisting of the amino acid sequence of SEQ ID NO:2 or SEQ ID NO:4, which peptide fragment, when administered to a member of a mammalian species, is capable of inducing the production of antibodies that bind specifically to a protein comprising the amino acid sequence from amino acid position 26 to amino acid position 286 of SEQ ID NO:2 or SEQ ID NO:4.
A recombinant expression vector, comprising a polynucleotide molecule comprising a nucleotide sequence encoding:
A recombinant expression vector, comprising a polynucleotide molecule consisting of a nucleotide sequence encoding:
A vaccine for protecting a member of a mammalian species against mastitis, comprising an immunologically effective amount of a polynucleotide molecule comprising a nucleotide sequence encoding:
A vaccine for protecting a member of species against mastitis, comprising an immunologically effective amount of a polynucleotide molecule comprising a nucleotide sequence encoding:
A combination vaccine for protecting a member of a mammalian species against mastitis and one or more diseases or pathological conditions that can afflict the mammal, which combination vaccine comprises an immunologically effective amount of a first component comprising a polynucleotide molecule comprising a nucleotide sequence encoding:
A combination vaccine for protecting a member of a mammalian species against mastitis and one or more diseases or pathological conditions that can afflict the mammal, which combination vaccine comprises an immunologically effective amount of a first component comprising a polynucleotide molecule comprising a nucleotide sequence encoding:
A method for determining whether an animal is infected with Streptococcus uberis, comprising analyzing a tissue or fluid sample from the animal for the presence of a polynucleotide molecule that encodes a protein comprising the amino acid sequence from amino acid position 26 to amino acid position 286 of SEQ ID NO:2 or SEQ ID NO:4.
Dependencies are inferred from the claim text.